Targeting monocyte chemotactic protein-1 synthesis with bindarit induces tumor regression in prostate and breast cancer animal models.
about
CCR2 deficiency promotes exacerbated chronic erosive neutrophil-dominated chikungunya virus arthritisImmunity of human epithelial ovarian carcinoma: the paradigm of immune suppression in cancerStromal characteristics may hold the key to mammographic density: the evidence to datePro-Tumoral Inflammatory Myeloid Cells as Emerging Therapeutic TargetsThe Role of Myeloid-Derived Suppressor Cells (MDSC) in Cancer ProgressionApigenin inhibits TNFα/IL-1α-induced CCL2 release through IKBK-epsilon signaling in MDA-MB-231 human breast cancer cellsTherapeutic strategies for targeting the ovarian tumor stroma.Diallyl disulfide inhibits TNFα-induced CCL2 release by MDA-MB-231 cells.Histone deacetylase inhibitor-temozolomide co-treatment inhibits melanoma growth through suppression of Chemokine (C-C motif) ligand 2-driven signals.Effects of the MCP-1 synthesis inhibitor bindarit on tumorigenesis and inflammatory markers in the C3(1)/SV40Tag mouse model of breast cancer.Linking tumor-associated macrophages, inflammation, and intestinal tumorigenesis: role of MCP-1Inhibition of CCL2 signaling in combination with docetaxel treatment has profound inhibitory effects on prostate cancer growth in bone.Targeting the tumor microenvironment: from understanding pathways to effective clinical trials.Circulating galectins -2, -4 and -8 in cancer patients make important contributions to the increased circulation of several cytokines and chemokines that promote angiogenesis and metastasis.Targeting the pro-inflammatory factor CCL2 (MCP-1) with Bindarit for influenza A (H7N9) treatment.Tumor microenvironment and myeloid-derived suppressor cells.Emerging role of tumor-associated macrophages as therapeutic targets in patients with metastatic renal cell carcinoma.Tumor-associated macrophages and anti-tumor therapies: complex links.Endothelial progenitors promote hepatocarcinoma intrahepatic metastasis through monocyte chemotactic protein-1 induction of microRNA-21.Macrophage Polarization: Anti-Cancer Strategies to Target Tumor-Associated Macrophage in Breast Cancer.PPM1A is a RelA phosphatase with tumor suppressor-like activity.Increased expression of C-C motif ligand 2 associates with poor prognosis in patients with gastric cancer after gastrectomy.Targeting nuclear factor-kappa B to overcome resistance to chemotherapy.Reprogramming of Tumor-Associated Macrophages with Anticancer Therapies: Radiotherapy versus Chemo- and ImmunotherapiesMyeloid-derived suppressor cells interact with tumors in terms of myelopoiesis, tumorigenesis and immunosuppression: thick as thieves.CCL2 at the crossroad of cancer metastasis.The Identification of Macrophage-enriched Glycoproteins Using Glycoproteomics.Combination of Carmustine and Selenite Inhibits EGFR Mediated Growth Signaling in Androgen-Independent Prostate Cancer Cells.NLR-Dependent Regulation of Inflammation in Multiple Sclerosis- Dependent Regulation of Inflammation in Multiple Sclerosis.Diamonds in the Rough: Harnessing Tumor-Associated Myeloid Cells for Cancer Therapy
P2860
Q24701793-59E111D0-790E-439C-83B4-62BD9F7E5321Q26996829-6620353D-621F-4727-B863-BC69419CCAD1Q28066162-1FC491B7-23F2-4CC1-A487-2C86A55FC7F3Q28076161-54ADE1C7-9B3B-4329-A209-912FC6C29332Q28076760-1A9A097D-0811-4206-809D-FECFEC3D2C4CQ33602761-6CD8438C-08DE-431A-B57F-D4B3B3270B31Q33770035-F04E3845-19C3-4DE1-A35E-1F9E80C1EEC0Q34056943-ACEB6A5A-4AEA-48B8-931D-81321A19E64AQ34101036-85DBB02A-62A7-450B-9EE7-F55CA23312BCQ35569609-6F648757-9F10-4399-97D6-0E5B6A35E7F4Q36454265-B861DD4B-6F26-4DED-8AC5-B4BF172E1A00Q36913771-C258F826-3833-47DB-A2EE-9687AA969339Q37274132-89E41754-8458-440A-B48B-EF9A25D37E66Q37559103-60AC83BF-9AC0-4B77-A3C3-610917578AD8Q37739368-684A8B54-EFED-4B58-9BC3-F60298DCB7EDQ38067642-714AFB91-4C23-402C-9672-A85FDFB8994BQ38153283-B79B0139-36DC-40A5-AE5B-A691754F5DC8Q38766176-45F8AA85-4E6C-46B8-BB1E-9309515E83C4Q38983644-3ECE6D79-261B-4E31-A4BB-009689436122Q39096364-844B4165-79D2-4159-8A35-16B18A72046BQ39132976-0C625691-2855-4289-9245-1A0943FF285DQ40465284-C4AF27DC-5A10-43C3-A3F2-F3862523A7BEQ40751673-850EA4BC-37FC-4D56-ABFE-BE37C1EDC4F1Q41011622-CD43AE46-202F-458A-B812-B02238E86F9DQ41952605-F8E120B9-4225-4776-8458-961F30148C31Q42136303-3DAD5D08-262A-48EF-AA48-EF264042B6A8Q46395675-EC3F8C57-2A47-486F-BF25-C07316FD4B46Q48248291-2506FFB8-903E-4582-87F6-28820E78BE5DQ49516622-718CB54A-0851-4C6E-8995-F2412A1E8C3CQ57817490-AFEBBDEE-61D8-4D35-AF57-4591CCD8C1CD
P2860
Targeting monocyte chemotactic protein-1 synthesis with bindarit induces tumor regression in prostate and breast cancer animal models.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Targeting monocyte chemotactic ...... d breast cancer animal models.
@en
Targeting monocyte chemotactic ...... d breast cancer animal models.
@nl
type
label
Targeting monocyte chemotactic ...... d breast cancer animal models.
@en
Targeting monocyte chemotactic ...... d breast cancer animal models.
@nl
prefLabel
Targeting monocyte chemotactic ...... d breast cancer animal models.
@en
Targeting monocyte chemotactic ...... d breast cancer animal models.
@nl
P2093
P2860
P1476
Targeting monocyte chemotactic ...... nd breast cancer animal models
@en
P2093
Angelo Guglielmotti
Beatrice Garrone
Daniela De Martino
Daniela Spano
Giorgina Mangano
Giuseppe Biondi
Lucia Liguori
Natascia Marino
Valeria Di Dato
Viviana Vastolo
P2860
P2888
P304
P356
10.1007/S10585-012-9473-5
P577
2012-04-07T00:00:00Z